Alfonso Valle
Alicante, VC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Vascular protection with rivaroxaban in the comprehensive management of atrial fibrillation.
Journal: Expert review of cardiovascular therapy
Published: November 07, 2023
Should atrial fibrillation be considered a vascular disease? The need for a comprehensive vascular approach.
Journal: Expert review of cardiovascular therapy
Published: October 24, 2023
Cardiorenal benefits of finerenone: protecting kidney and heart.
Journal: Annals of medicine
Published: January 31, 2023
Short-term Changes in Hemoglobin and Changes in Functional Status, Quality of Life and Natriuretic Peptides After Initiation of Dapagliflozin in Heart Failure With Reduced Ejection Fraction.
Journal: Journal of cardiac failure
Published: January 17, 2023
Early glomerular filtration rate decline is associated with hemoglobin rise following dapagliflozin initiation in heart failure with reduced ejection fraction.
Journal: Revista espanola de cardiologia (English ed.)
Published: November 07, 2022
Dapagliflozin and short-term changes on circulating antigen carbohydrate 125 in heart failure with reduced ejection fraction.
Journal: Scientific reports
Published: October 26, 2022
Mortality and Heart Failure Risk Reductions in Patients Treated With Sacubitril-Valsartan in Clinical Trials.
Journal: American journal of therapeutics
Published: September 08, 2022
Finerenone: towards a holistic therapeutic approach to patients with diabetic kidney disease.
Journal: Nefrologia
Published: July 14, 2022
Effect of PCSK9 inhibitors on remnant cholesterol and lipid residual risk: The LIPID-REAL registry.
Journal: European journal of clinical investigation
Published: June 30, 2022
Short-term effects of dapagliflozin on maximal functional capacity in heart failure with reduced ejection fraction (DAPA-VO2 ): a randomized clinical trial.
Journal: European journal of heart failure
Published: April 25, 2022
Patients With High Cardiovascular Risk as Candidates to Bempedoic Acid, After Treatment With Statins, Ezetimibe and PCSK9 Inhibitors: An Estimation and Cost-Effectiveness Analysis.
Journal: Journal of cardiovascular pharmacology
Published: April 02, 2022
Bending oxygen saturation index and risk of worsening heart failure events in chronic heart failure.
Bending oxygen saturation index and risk of worsening heart failure events in chronic heart failure.
Journal: European journal of heart failure
Published: March 12, 2022
Last Updated: 09/26/2026